Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- Check6 days agoChange DetectedPage revision metadata updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedGlossary display added and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) appear with Revision: v3.4.0. Older metadata entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4) have been removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows a minor revision update (Revision: v3.3.4 added; Revision: v3.3.3 removed). This update does not affect study details or core user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Locations section was expanded to include numerous new recruitment sites across US states (California, Delaware, Florida, Georgia, Illinois, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, Washington) and international locations (New South Wales, Western Australia, Gangnam-gu, Canton of Vaud, England), while several location entries were removed.SummaryDifference2%

- Check78 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2, with no apparent changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded numerous new trial sites across Spain, France, Italy, Canada, and the United States, expanding the study's geographic footprint.SummaryDifference3%

Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.